Author:
Rhee Moo-Yong,Baek Sang Hong,Kim Weon,Park Chang Gyu,Park Seung Woo,Oh Byung-Hee,Kim Sang Hyun,Kim Jae-Joong,Shin Joon-Han,Yoo Byung-Su,Rim Se-Joong,Ha Jong-Won,Doh Joon Hyung,Ahn Young keun,Chae Jei Keon,Park Jeong Bae,Kim Soon-Kil,Kim Cheol Ho
Subject
Drug Discovery,Pharmaceutical Science,Pharmacology
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Contribution of single-pill combinations in the management of hypertension: perspectives from China, Europe and the USA;Current Medical Research and Opinion;2023-01-20
2. A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy;Clinical Hypertension;2022-12-01
3. Simultaneous Analysis of a Combination of Anti-Hypertensive Drugs, Fimasartan, Amlodipine, and Hydrochlorothiazide, in Rats Using LC-MS/MS and Subsequent Application to Pharmacokinetic Drug Interaction with Red Ginseng Extract;Toxics;2022-09-30
4. Newer Angiotensin Receptor Blockers;Hypertension and Cardiovascular Disease in Asia;2022
5. Efficacy of ARB/HCTZ Combination Therapy in Uncontrolled Hypertensive Patients Compared with ARB Monotherapy: A Meta-Analysis;International Journal of Hypertension;2021-04-27